David Saxon

Stock Analyst at Needham

(0.64)
# 3,886
Out of 4,405 analysts
486
Total ratings
34%
Success rate
-1.9%
Average return

Stocks Rated by David Saxon

Glaukos
Jun 11, 2026
Maintained: Buy
Price Target: $136
Current: $126.81
Upside: +7.25%
The Cooper Companies
Jun 5, 2026
Rated: Buy
Price Target: $101$86
Current: $67.88
Upside: +26.69%
SI-BONE
Jun 3, 2026
Reiterated: Buy
Price Target: $27
Current: $15.42
Upside: +75.10%
STAAR Surgical Company
May 14, 2026
Maintained: Hold
Price Target: n/a
Current: $28.37
Upside: -
Globus Medical
May 8, 2026
Reiterated: Buy
Price Target: $114$117
Current: $80.39
Upside: +45.54%
Envista Holdings
May 7, 2026
Maintained: Hold
Price Target: $27
Current: $24.60
Upside: +9.76%
Sight Sciences
May 7, 2026
Maintained: Hold
Price Target: n/a
Current: $5.13
Upside: -
RxSight
May 7, 2026
Reiterated: Buy
Price Target: $13$11
Current: $4.71
Upside: +133.55%
Alphatec Holdings
May 6, 2026
Reiterated: Buy
Price Target: $25$14
Current: $8.28
Upside: +69.08%
Azenta
May 6, 2026
Reiterated: Buy
Price Target: $44$33
Current: $22.59
Upside: +46.08%
Maintained: Hold
Price Target: n/a
Current: $10.09
Upside: -
Reiterated: Buy
Price Target: CHF 79.78CHF 75.79
Current: $53.16
Upside: +42.57%
Rated: Buy
Price Target: $13$15
Current: $14.62
Upside: +2.60%
Reiterated: Buy
Price Target: $254$255
Current: $113.65
Upside: +124.37%
Maintained: Hold
Price Target: $184
Current: $174.84
Upside: +5.24%
Maintained: Hold
Price Target: n/a
Current: $15.08
Upside: -